RALEIGH, N.C., Oct. 10, 2017 -- Highwoods Properties, Inc. (NYSE:HIW) will release its 2017 third quarter results on Tuesday, October 24th, after the market closes.
A conference call will be held the next day, Wednesday, October 25th, at 11:00 A.M. Eastern time.
For US/Canada callers, dial (800) 756-3565. A live, listen-only webcast can be accessed through the Company’s website at www.highwoods.com under the “Investor Relations” section. A replay of the call will also be available on the Company’s website.
About Highwoods
Highwoods Properties, Inc., headquartered in Raleigh, is a publicly-traded (NYSE:HIW) real estate investment trust (“REIT”) and a member of the S&P MidCap 400 Index. The Company is a fully-integrated office REIT that owns, develops, acquires, leases and manages properties primarily in the best business districts (BBDs) of Atlanta, Greensboro, Memphis, Nashville, Orlando, Pittsburgh, Raleigh, Richmond and Tampa. For more information about Highwoods, please visit our website at www.highwoods.com.
Contact: Brendan Maiorana Senior Vice President, Finance and Investor Relations 919-431-1529


Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 



